The France respiratory device market was valued at around $588 million in 2018 and is estimated to grow at a CAGR of around 5.3% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in the country. Further, well-developed healthcare infrastructure is also fueling the growth of the country’s market. As per French government agency, Business France, the country ranked as 4th globally and second in Europe for the medical device and technology market. There are about 1,300 to 1,350 companies in French device manufacturer generating a revenue of about $32 billion in 2017. The country is generating about $9.5 billion in 2017 by the export of medical devices. The medical device market is providing employment to about 85,000 people in the country.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/france-respiratory-device-market
The France respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/france-respiratory-device-market
Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. Some of the key players of the market include ResMed Corp., Chiesi Farmaceutici S.P.A., GlaxoSmithKline PLC, 3M Co., Novartis AG, Teicos Pharma Ltd., and others. Air Liquide S.A. is the major respiratory company operating in France. In April 2018, the company acquired a French start-up company EOVE for the extension of service offering of home healthcare activities. In January 2018 the company acquired the respiratory division of Thimar Al Jazirah Company (TAC) for geographical expansion and enter into the Saudi Arabia market. In September 2017, Air Liquide acquired Sogo Sangyo Kabushiki Kaisha for expanding its healthcare business in Japan.
Market Segmentation
France Respiratory Device Market by Product
- Therapeutic Devices
- Diagnostic and Monitoring Devices
- Consumable and Accessories
France Respiratory Device Market by End-User
- Homecare
- Hospitals and Clinics
Company Profiles
- 3M Co.
- Acorda Therapeutics, Inc.
- Adamis Pharmaceuticals Corp.
- Adherium Ltd.
- Air Liquide S.A.
- AstraZeneca PLC
- Bespak
- Boehringer Ingelheim International GmbH
- Chiesi Farmaceutici S.P.A.
- Gilbert Technologies B.V.
- GlaxoSmithKline PLC
- H&T Presspart Manufacturing Ltd.
- Hamilton Medical AG
- Koninklijke Philips N.V.
- Medtronic PLC
- Novartis AG
- PMD Device Solutions Ltd.
- ResMed Corp.
- Savara, Inc.
- Teicos Pharma Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Vitalograph Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/france-respiratory-device-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
